Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05442060 |
| Consolidated Lead Sponsor | OBI Pharma |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 60 participants (ESTIMATED) |
| Registered Start Date | 2022-07-27 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Taipei Veterans General Hospital | Taipei, Taiwan | Open Hospital Dossier -> |
| Linkou Chang Gung Memorial Hospital | Taoyuan, Taiwan | Open Hospital Dossier -> |
| Tri-Service General Hospital | Taipei, Taiwan | Open Hospital Dossier -> |
| National Taiwan University Hospital | Taipei, Taiwan | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.